The role of dendritic cells in fibrosis progression in nonalcoholic fatty liver disease

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Almeda Valdes, Paloma ^a   Aguilar Olivos, Nancy E ^b   Barranco Fragoso, Beatriz ^c   Uribe, Misael ^b   Méndez Sánchez, Nahum ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b LIVER RESEARCH UNIT   (Mexico)

^c Department of Gastroenterology National Medical Center 20 Noviembre   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; DENDRITIC CELL; DISEASE COURSE; HISTOCOMPATIBILITY COMPLEX; HUMAN; KUPFFER CELL; LIVER CELL; LIVER FIBROSIS; LIVER PARENCHYMA; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER T CELL; NONALCOHOLIC FATTY LIVER; REGULATORY T LYMPHOCYTE; INFLAMMATION; LIPID METABOLISM; LIVER; LIVER CIRRHOSIS; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PATHOLOGY;

DENDRITIC CELLS; DISEASE PROGRESSION; HUMANS; INFLAMMATION; LIPID METABOLISM; LIVER; LIVER CIRRHOSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 84939549306     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/768071     Document Type: Article

References (62)

1. J. A. Ĺopez-Veĺazquez, K. V. Silva-Vidal, G. Ponciano-Rodríguez et al. , "The prevalence of nonalcoholic fatty liver disease in the Americas," Annals of Hepatology, vol. 13, no. 2, pp. 166-178, 2014.
2. P. Babusik, M. Bilal, and I. Duris, "Nonalcoholic fatty liver disease of two ethnic groups in Kuwait: comparison of prevalence and risk factors," Medical Principles and Practice, vol. 21, no. 1, pp. 56-62, 2011.
3. G. Bedogni, L. Miglioli, F. Masutti, C. Tiribelli, G. Marchesini, and S. Bellentani, "Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study," Hepatology, vol. 42, no. 1, pp. 44-52, 2005.
4. L. Caballería, G. Pera, M. A. Auladell et al. , "Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain," European Journal of Gastroenterology and Hepatology, vol. 22, no. 1, pp. 24-32, 2010.
5. V. Ratziua, S. Bellentanib, H. Cortez-Pintoc, C. Dayd, and G. Marchesinie, "A position statement onNAFLD/NASHbased on the EASL 2009 special conference," Journal of Hepatology, vol. 53, no. 2, pp. 372-384, 2010.
6. J. G. Fan, J. D. Jia, Y. M. Li et al. , "Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166)," Journal of Digestive Diseases, vol. 12, no. 1, pp. 38-44, 2011.
7. N. Méndez-͆anchez, M. Arrese, D. Zamora-Valdés, and M. Uribe, "Current concepts in the pathogenesis of nonalcoholic fatty liver disease," Liver International, vol. 27, no. 4, pp. 423-433, 2007.
8. P. Handa and K. V. Kowdley, "Dendritic cells in NASH: friend or foe?"Annals of Hepatology, vol. 12, no. 3, pp. 508-509, 2013.
9. W. Hsu, S.-A. Shu, E. Gershwin, and Z.-X. Lian, "The current immune function of hepatic dendritic cells. ," Cellular and Molecular Immunology, vol. 4, no. 5, pp. 321-328, 2007.
10. A. W. Thomson and P. A. Knolle, "Antigen-presenting cell function in the tolerogenic liver environment," Nature Reviews Immunology, vol. 10, no. 11, pp. 753-766, 2010.
11. A. H. Rahman and C. Aloman, "Dendritic cells and liver fibrosis," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1832, no. 7, pp. 998-1004, 2013.
12. A. Kelly, E. J. Ryan, and C. OFarrelly, "Reply to: dendritic cell subset composition in the human liver is more complex than it seems," Journal ofHepatology, vol. 60, no. 5, pp. 1098-1099, 2014.
13. I. Jomantaite, N. Dikopoulos, A. Kröger et al. , "Hepatic dendritic cell subsets in the mouse," European Journal of Immunology, vol. 34, no. 2, pp. 355-365, 2004.
14. L. Chen, E. Calomeni, J. Wen, K. Ozato, R. Shen, and J.-X. Gao, "Natural killer dendritic cells are an intermediate of developing dendritic cells," Journal of Leukocyte Biology, vol. 81, no. 6, pp. 1422-1433, 2007.
15. V. Kumar, "NKT-cell subsets: promoters and protectors in inflammatory liver disease," Journal of Hepatology, vol. 59, no. 3, pp. 618-620, 2013.
16. M. Guebre-Xabier, S. Yang, H. Z. Lin, R. Schwenk, U. Krzych, and A. M. Diehl, "Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage," Hepatology, vol. 31, no. 3, pp. 633-640, 2000.
17. M. Kremer, E. Thomas, R. J. Milton et al. , "Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis," Hepatology, vol. 51, no. 1, pp. 130-141, 2010.
18. Y.-T. Zhan and W. An, "Roles of liver innate immune cells in nonalcoholic fatty liver disease,"World Journal of Gastroenterology, vol. 16, no. 37, pp. 4652-4660, 2010.
19. W.-K. Syn, Y. H. Oo, T. A. Pereira et al. , "Accumulationofnatural killer T cells in progressive nonalcoholic fatty liver disease," Hepatology, vol. 51, no. 6, pp. 1998-2007, 2010.
20. Z. Trobonjaca, F. Leithäuser, P. Möller, R. Schirmbeck, and J. Reimann, "Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells,"The Journal of Immunology, vol. 167, no. 3, pp. 1413-1422, 2001.
21. A. Boltjes and F. van Wijk, "Human dendritic cell functional specialization in steady-state and inflammation," Frontiers in Immunology, vol. 5, article 131, Article ID Article 131, 2014.
22. J. Banchereau and R. M. Steinman, "Dendritic cells and the control of immunity," Nature, vol. 392, no. 6673, pp. 245-252, 1998.
23. I. Mellman and R. M. Steinman, "Dendritic cells: specialized and regulated antigen processing machines," Cell, vol. 106, no. 3, pp. 255-258, 2001.
24. G. Schuler and R. M. Steinman, "Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro,"The Journal of Experimental Medicine, vol. 161, no. 3, pp. 526-546, 1985.
25. P. G. Holt, M. A. Schon-Hegrad, J. Oliver, B. J. Holt, and P. G. McMenamin, "A contiguous network of dendritic antigenpresenting cells within the respiratory epithelium," International Archives of Allergy and Applied Immunology, vol. 91, no. 2, pp. 155-159, 1990.
26. D. N. J. Hart and J. W. Fabre, "Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissue of rat heart and other tissues, but not brain," Journal of Experimental Medicine, vol. 154, no. 2, pp. 347-361, 1981.
27. D. N. J. Hart and J. L. McKenzie, "Isolation and characterization of human tonsil dendritic cells," Journal of Experimental Medicine, vol. 168, no. 1, pp. 157-170, 1988.
28. R. Bujdoso, J. Hopkins, B. M. Dutia, P. Young, and I. McConnell, "Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage," The Journal of Experimental Medicine, vol. 170, no. 4, pp. 1285-1302, 1989.
29. M. V. Dhodapkar, R. M. Steinman, M. Sapp et al. , "Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells," The Journal of Clinical Investigation, vol. 104, no. 2, pp. 173-180, 1999.
30. R. M. Steinman, S. Turley, I. Mellman, and K. Inaba, "The induction of tolerance by dendritic cells that have capturedapoptotic cells," Journal of Experimental Medicine, vol. 191, no. 3, pp. 411-416, 2000.
31. D. Hawiger, K. Inaba, Y. Dorsett et al. , "Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo," Journal of Experimental Medicine, vol. 194, no. 6, pp. 769-779, 2001.
32. C. R. Sousa, P. D. Stahl, and J. M. Austyn, "Phagocytosis of antigens by Langerhans cells in vitro," Journal of Experimental Medicine, vol. 178, no. 2, pp. 509-519, 1993.
33. W. Jian, W. J. Swiggard, C. Heufler et al. , "The receptor DEC-expressed by dendritic cells and thymic epithelial cells is involved in antigen processing," Nature, vol. 375, no. 6527, pp. 151-155, 1995.
34. P. Pierre, S. J. Turley, E. Gatti et al. , "Developmental regulation ofMHC class II transport inmouse dendritic cells," Nature, vol. 388, no. 6644, pp. 787-792, 1997.
35. K. Inaba, S. Turley, T. Iyoda et al. , "The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli," The Journal of Experimental Medicine, vol. 191, no. 6, pp. 927-936, 2000.
36. R. M. Steinman and M. C. Nussenzweig, "Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 351-358, 2002.
37. C. Buelens, V. Verhasselt, D. de Groote, K. Thielemans, M. Goldman, and F. Willems, "Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10," European Journal of Immunology, vol. 27, no. 8, pp. 1848-1852, 1997.
38. T. A. Springer, "Traffic signals for lymphocyte recirculation and leukocyte emigration: themultistep paradigm," Cell, vol. 76, no. 2, pp. 301-314, 1994.
39. C. Caux, C. Massacrier, B. Vanbervliet et al. , "Activation of human dendritic cells through CD40 cross-linking," Journal of Experimental Medicine, vol. 180, no. 4, pp. 1263-1272, 1994.
40. S. J. Turley, K. Inaba, W. S. Garrett et al. , "Transport of peptide-MHC class II complexes in developing dendritic cells," Science, vol. 288, no. 5465, pp. 522-527, 2000.
41. S.-Y. Tseng, M. Otsuji, K. Gorski et al. , "B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells," Journal of Experimental Medicine, vol. 193, no. 7, pp. 839-845, 2001.
42. S. Ebner, G. Ratzinger, B. Krösbacher et al. , "Production of IL-by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4," The Journal of Immunology, vol. 166, no. 1, pp. 633-641, 2001.
43. S. Sozzani, P. Allavena, A. Vecchi, and A. Mantovani, "The role of chemokines in the regulation of dendritic cell trafficking," Journal of Leukocyte Biology, vol. 66, no. 1, pp. 1-9, 1999.
44. F. Sallusto, P. Schaerli, P. Loetscher et al. , "Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation," European Journal of Immunology, vol. 28, no. 9, pp. 2760-2769, 1998.
45. M. Cella, A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia, "Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells," Nature, vol. 388, no. 6644, pp. 782-787, 1997.
46. C. Reis E Sousa, S. Hieny, T. Scharton-Kersten et al. , "In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas," Journal of Experimental Medicine, vol. 186, no. 11, pp. 1819-1829, 1997.
47. M. V. Dhodapkar, J. Krasovsky, R. M. Steinman, and N. Bhardwaj, "Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes," The Journal of Clinical Investigation, vol. 105, no. 6, pp. R9-R14, 2000.
48. C. P. Larsen, R. M. Steinman, M. Witmer-Pack, D. F. Hankins, P. J. Morris, and J. M. Austyn, "Migration and maturation of Langerhans cells in skin transplants and explants," Journal of Experimental Medicine, vol. 172, no. 5, pp. 1483-1493, 1990.
49. A. H. Enk and S. I. Katz, "Early molecular events in the induction phase of contact sensitivity," Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 4, pp. 1398-1402, 1992.
50. G. Schuler and R. M. Steinman, "Dendritic cells as adjuvants for immune-mediated resistance to tumors," Journal of Experimental Medicine, vol. 186, no. 8, pp. 1183-1187, 1997.
51. A. Bender, L. K. Bui, M. A. V. Feldman, M. Larsson, and N. Bhardwaj, "Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses," Journal of Experimental Medicine, vol. 182, no. 6, pp. 1663-1671, 1995.
52. R. Xu, Z. Zhang, and F.-S. Wang, "Liver fibrosis: mechanisms of immune-mediated liver injury," Cellular and Molecular Immunology, vol. 9, no. 4, pp. 296-301, 2012.
53. R. Bataller and D. A. Brenner, "Liver fibrosis," The Journal of Clinical Investigation, vol. 115, no. 2, pp. 209-218, 2005.
54. R. Fischer, A. Cariers, R. Reinehr, and D. Häussinger, "Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells," Gastroenterology, vol. 123, no. 3, pp. 845-861, 2002.
55. Y.-H. Paik, R. F. Schwabe, R. Bataller, M. P. Russo, C. Jobin, and D. A. Brenner, "Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells," Hepatology, vol. 37, no. 5, pp. 1043-1055, 2003.
56. K. Iwaisako, K. Taura, Y. Koyama, K. Takemoto, and M. Asagiri, "Strategies to detect hepatic myofibroblasts in liver cirrhosis of different etiologies," Current Pathobiology Reports, vol. 2, no. 4, pp. 209-215, 2014.
57. H. Sahin and H. E. Wasmuth, "Chemokines in tissue fibrosis," Biochimica et Biophysica Acta, vol. 1832, no. 7, pp. 1041-1048, 2013.
58. V. Lukacs-Kornek and D. Schuppan, "Dendritic cells in liver injury and fibrosis: shortcomings and promises," Journal of Hepatology, vol. 59, no. 5, pp. 1124-1126, 2013.
59. M. K. Connolly, A. S. Bedrosian, J. Mallen-St. Clair et al. , "In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-α," The Journal of Clinical Investigation, vol. 119, no. 11, pp. 3213-3225, 2009.
60. J. Ibrahim, A. H. Nguyen, A. Rehman et al. , "Dendritic cell populations with different concentrations of lipid regulate tolerance andimmunity inmouse and human liver,"Gastroenterology, vol. 143, no. 4, pp. 1061-1072, 2012.
61. J. Jiao, D. Sastre, M. I. Fiel et al. , "Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression," Hepatology, vol. 55, no. 1, pp. 244-255, 2012.
62. J. R. Henning, C. S. Graffeo, A. Rehman et al. , "Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice," Hepatology, vol. 58, no. 2, pp. 589-602, 2013.